Ebru Afşar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ebru Afşar has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alev Duygu Acun
AKDENİZ ÜNİVERSİTESİ, TIP FAKÜLTESİ
4 shared publications - Işıl Eranıl
Department of Medical Services and Techniques, Cappadocia Vocational School Cappadocia University Nevşehir Turkey
4 shared publications - Deniz Kantar
Faculty of Medicine, Akdeniz University, Antalya, Turkey
3 shared publications - Mehmet Öz
Department of Physiology, Faculty of Medicine, Aksaray University, Aksaray, Turkiye
3 shared publications - Erdem Arslan
Department of Medical Pharmacology, Faculty of Medicine, Aksaray University, Aksaray, Turkey
2 shared publications - Erkan Özkan
Department of Parasitology, Faculty of Veterinary Medicine Aksaray University Aksaray Turkey
2 shared publications
Latest Publications
- Open Access
- 16 June 2026
- Published by Kastamonu University in Kastamonu Medical Journal
- Vol. 6 (2) , 120-126
Effect of the hypothalamic serotonin on body weight change in the context of brain insulin resistance in Alzheimer’s disease
Aims: The present work was designed to evaluate how alterations in serotonin (5-hydroxytryptamine, 5-HT), 5-HT receptor subtype 2B (5-HT2BR), and neuropeptide Y (NPY) are associated with body weight regulation in a rat model of brain insulin resistance (B-IR) that mimics the early pathological features of Alzheimer’s disease (AD).Methods: B-IR was induced in rats through intracerebroventricular (i.c.v.) administration of amyloid-β₁–₄₂ oligomers at a dose of 2.5 nmol in a total volume of 10 μL. 5-HT concentrations were quantified in brainstem and hypothalamic samples, while hypothalamic levels of 5-HT2BR and NPY were determined using enzyme-linked immunosorbent assay (ELISA) methods. Body weight variation for each animal was defined as the difference between post-experimental and initial measurements. Group comparisons were conducted using the Mann–Whitney U test, and statistical significance was accepted at p < 0.05.Results: Rats in the B-IR group showed a tendency toward increased 5-HT levels in brainstem tissue compared to the control group (p > 0.05), whereas hypothalamic 5-HT levels were significantly decreased in the B-IR group compared to controls (p < 0.01); body weight was significantly reduced in the B-IR group compared to the control group (p 0.05 for both).Conclusion: These findings suggest that decreased hypothalamic 5-HT levels in the B-IR group may be associated with the observed reduction in body weight. Additionally, the downward trends observed in 5-HT2BR and NPY levels may also be related to this change.
- 16 June 2026
- Published by Kastamonu University in Kastamonu Medical Journal
- Vol. 6 (2) , 120-126
Open AccessEffect of the hypothalamic serotonin on body weight change in the context of brain insulin resistance in Alzheimer’s disease
Aims: The present work was designed to evaluate how alterations in serotonin (5-hydroxytryptamine, 5-HT), 5-HT receptor subtype 2B (5-HT2BR), and neuropeptide Y (NPY) are associated with body weight regulation in a rat model of brain insulin resistance (B-IR) that mimics the early pathological features of Alzheimer’s disease (AD).Methods: B-IR was induced in rats through intracerebroventricular (i.c.v.) administration of amyloid-β₁–₄₂ oligomers at a dose of 2.5 nmol in a total volume of 10 μL. 5-HT concentrations were quantified in brainstem and hypothalamic samples, while hypothalamic levels of 5-HT2BR and NPY were determined using enzyme-linked immunosorbent assay (ELISA) methods. Body weight variation for each animal was defined as the difference between post-experimental and initial measurements. Group comparisons were conducted using the Mann–Whitney U test, and statistical significance was accepted at p < 0.05.Results: Rats in the B-IR group showed a tendency toward increased 5-HT levels in brainstem tissue compared to the control group (p > 0.05), whereas hypothalamic 5-HT levels were significantly decreased in the B-IR group compared to controls (p < 0.01); body weight was significantly reduced in the B-IR group compared to the control group (p 0.05 for both).Conclusion: These findings suggest that decreased hypothalamic 5-HT levels in the B-IR group may be associated with the observed reduction in body weight. Additionally, the downward trends observed in 5-HT2BR and NPY levels may also be related to this change.
- Open Access
- 12 June 2026
- Published by Wiley in Journal of Applied Toxicology
Epirubicin Alters Pancreatic Autophagy and Insulin Synthesis Through a Zinc‐Dependent Mechanism
Epirubicin (EPI) can cause metabolic side effects, including chemotherapy‐related diabetes, partly through oxidative stress that disrupts zinc (Zn) homeostasis and impairs autophagy. This study investigated the effects of EPI on Zn regulation and autophagy in the pancreas, as well as the modulatory role of N ‐acetylcysteine (NAC). Rats received EPI (9.6 mg/kg) by intraperitoneal injection (i.p.) followed 1 h later by NAC (50 or 300 mg/kg, i.p.). Glucose homeostasis was assessed using the Homeostatic Model Assessment (HOMA‐IR), and β‐cell function was assessed using HOMA‐β levels. Plasma insulin levels, as well as insulin, proinsulin, beclin, autophagy‐related proteins (ATG5), Microtubule‐Associated Protein 1 Light Chain 3 (LC3), phosphorylated Akt (p‐Akt), mechanistic target of rapamycin complex 1 (mTOR1), cleaved caspase‐3, Zrt/Irt‐like Protein 10 (ZIP10), and the proliferation marker Ki‐67 in pancreatic tissue, were measured using commercial ELISA kits. Total oxidant status (TOS) and total antioxidant status (TAS) were measured using commercial colorimetric assay kits, and the oxidative stress index (OSI) was calculated. Zn levels in pancreatic tissue and plasma samples were measured using a colorimetric method. Morphological changes in the pancreas were assessed by hematoxylin and eosin staining. As a result, in the EPI group, oxidative stress and ZIP10 levels increased, whereas Zn levels decreased, as well as pancreatic autophagy, proliferation, and insulin synthesis increased. Oxidative stress decreased in both the EN‐50 and EN‐300 groups, with a more pronounced decrease in the EN‐300 group. Furthermore, in the EN‐300 group, pancreatic Zn, ZIP10, autophagy, and proliferation levels decreased, whereas mTOR1 levels increased. The pancreatic insulin synthesis observed in the EN‐50 group was not observed in the EN‐300 group. In conclusion, the increased autophagy observed in the Epi group may reflect an adaptive response to oxidative stress. The effects of NAC on oxidative stress may be dose‐dependent, and high‐dose NAC administration may suppress EPI‐induced autophagy via mTOR1‐mediated signaling. Furthermore, the relationship among Zn levels, autophagy, and insulin synthesis observed in the experimental groups may contribute to a better understanding of EPI‐associated diabetogenic alterations.
- 12 June 2026
- Published by Wiley in Journal of Applied Toxicology
Open AccessEpirubicin Alters Pancreatic Autophagy and Insulin Synthesis Through a Zinc‐Dependent Mechanism
Epirubicin (EPI) can cause metabolic side effects, including chemotherapy‐related diabetes, partly through oxidative stress that disrupts zinc (Zn) homeostasis and impairs autophagy. This study investigated the effects of EPI on Zn regulation and autophagy in the pancreas, as well as the modulatory role of N ‐acetylcysteine (NAC). Rats received EPI (9.6 mg/kg) by intraperitoneal injection (i.p.) followed 1 h later by NAC (50 or 300 mg/kg, i.p.). Glucose homeostasis was assessed using the Homeostatic Model Assessment (HOMA‐IR), and β‐cell function was assessed using HOMA‐β levels. Plasma insulin levels, as well as insulin, proinsulin, beclin, autophagy‐related proteins (ATG5), Microtubule‐Associated Protein 1 Light Chain 3 (LC3), phosphorylated Akt (p‐Akt), mechanistic target of rapamycin complex 1 (mTOR1), cleaved caspase‐3, Zrt/Irt‐like Protein 10 (ZIP10), and the proliferation marker Ki‐67 in pancreatic tissue, were measured using commercial ELISA kits. Total oxidant status (TOS) and total antioxidant status (TAS) were measured using commercial colorimetric assay kits, and the oxidative stress index (OSI) was calculated. Zn levels in pancreatic tissue and plasma samples were measured using a colorimetric method. Morphological changes in the pancreas were assessed by hematoxylin and eosin staining. As a result, in the EPI group, oxidative stress and ZIP10 levels increased, whereas Zn levels decreased, as well as pancreatic autophagy, proliferation, and insulin synthesis increased. Oxidative stress decreased in both the EN‐50 and EN‐300 groups, with a more pronounced decrease in the EN‐300 group. Furthermore, in the EN‐300 group, pancreatic Zn, ZIP10, autophagy, and proliferation levels decreased, whereas mTOR1 levels increased. The pancreatic insulin synthesis observed in the EN‐50 group was not observed in the EN‐300 group. In conclusion, the increased autophagy observed in the Epi group may reflect an adaptive response to oxidative stress. The effects of NAC on oxidative stress may be dose‐dependent, and high‐dose NAC administration may suppress EPI‐induced autophagy via mTOR1‐mediated signaling. Furthermore, the relationship among Zn levels, autophagy, and insulin synthesis observed in the experimental groups may contribute to a better understanding of EPI‐associated diabetogenic alterations.
- 20 February 2026
- Published by Wiley in Journal of Applied Toxicology
- Vol. 46 (9) , 3244-3256
Hepato‐Cardiac Axis in Epirubicin Toxicity: Role of Kynurenine Pathway and N‐Acetylcysteine Antioxidant Intervention
Epirubicin (EPI) is a widely used chemotherapeutic agent; however, its clinical utility is limited by severe side effects, particularly the production of reactive oxygen species (ROS). Among these, cardiotoxicity is one of the most critical issues, and it is worsened by impaired hepatic clearance resulting from liver dysfunction. This study aimed to investigate molecular changes induced by EPI in the liver within the kynurenine pathway (KP), their possible contribution to cardiotoxicity, and the protective effects of N‐acetylcysteine (NAC). Rats received intraperitoneal injections of 50 or 300 mg/kg NAC, followed 1 h later by 9.6 mg/kg EPI. Tryptophan (Trp), kynurenine (Kyn), kynurenic acid (KYNA), quinolinic acid (QA), kynureninase, and kynurenine 3‐monooxygenase (KMO) levels in the liver and cleaved caspase‐3 levels in the liver and heart tissue were measured using ELISA. Hepatic and cardiac total antioxidant status (TAS) and total oxidant status (TOS) were determined using a colorimetric method. Plasma levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatine kinase (CK), creatine kinase–MB isoenzyme (CK‐MB), high‐density lipoprotein (HDL), low‐density lipoprotein (LDL), total cholesterol (T‐chol), and triglyceride (TG) were analyzed with a clinical biochemistry analyzer. Cardiac morphology was examined using hematoxylin–eosin staining. EPI administration was associated with increases in plasma CK‐MB, the AST/ALT ratio, LDL, T‐chol, and TG, with these increases partially attenuated by NAC treatment. Hepatic levels of Trp, QA, and KMO were positively correlated with plasma CK‐MB and the AST/ALT ratio. Additionally, EPI appeared to increase oxidative stress in heart tissue and induce morphological changes. At the same time, NAC treatment was associated with partial improvement in these parameters, suggesting that alterations in the hepatic KP may be linked to possible cardiac involvement. Our findings suggest that EPI‐induced alterations in hepatic KP may impair hepatic clearance, and NAC administration may provide partial protection, warranting further investigation of a possible hepato‐cardiac interaction.
- 20 February 2026
- Published by Wiley in Journal of Applied Toxicology
- Vol. 46 (9) , 3244-3256
Hepato‐Cardiac Axis in Epirubicin Toxicity: Role of Kynurenine Pathway and N‐Acetylcysteine Antioxidant Intervention
Epirubicin (EPI) is a widely used chemotherapeutic agent; however, its clinical utility is limited by severe side effects, particularly the production of reactive oxygen species (ROS). Among these, cardiotoxicity is one of the most critical issues, and it is worsened by impaired hepatic clearance resulting from liver dysfunction. This study aimed to investigate molecular changes induced by EPI in the liver within the kynurenine pathway (KP), their possible contribution to cardiotoxicity, and the protective effects of N‐acetylcysteine (NAC). Rats received intraperitoneal injections of 50 or 300 mg/kg NAC, followed 1 h later by 9.6 mg/kg EPI. Tryptophan (Trp), kynurenine (Kyn), kynurenic acid (KYNA), quinolinic acid (QA), kynureninase, and kynurenine 3‐monooxygenase (KMO) levels in the liver and cleaved caspase‐3 levels in the liver and heart tissue were measured using ELISA. Hepatic and cardiac total antioxidant status (TAS) and total oxidant status (TOS) were determined using a colorimetric method. Plasma levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatine kinase (CK), creatine kinase–MB isoenzyme (CK‐MB), high‐density lipoprotein (HDL), low‐density lipoprotein (LDL), total cholesterol (T‐chol), and triglyceride (TG) were analyzed with a clinical biochemistry analyzer. Cardiac morphology was examined using hematoxylin–eosin staining. EPI administration was associated with increases in plasma CK‐MB, the AST/ALT ratio, LDL, T‐chol, and TG, with these increases partially attenuated by NAC treatment. Hepatic levels of Trp, QA, and KMO were positively correlated with plasma CK‐MB and the AST/ALT ratio. Additionally, EPI appeared to increase oxidative stress in heart tissue and induce morphological changes. At the same time, NAC treatment was associated with partial improvement in these parameters, suggesting that alterations in the hepatic KP may be linked to possible cardiac involvement. Our findings suggest that EPI‐induced alterations in hepatic KP may impair hepatic clearance, and NAC administration may provide partial protection, warranting further investigation of a possible hepato‐cardiac interaction.
- 14 January 2026
- Published by Wiley in Journal of Applied Toxicology
- Vol. 46 (4) , 1372-1388
Maternal Immune Activation Disrupts Autophagy and Glucose Homeostasis: Experimental Evidence for the Protective Effects of N‐Acetylcysteine on Maternal and Offspring Outcomes in a Rat Model
Maternal immune activation during pregnancy has been shown to disrupt maternal glucose regulation, predisposing the mother to postpartum diabetic conditions while also exerting long‐lasting metabolic effects on the offspring. This study aimed to investigate the impact of lipopolysaccharide (LPS)‐induced maternal immune activation on glucose homeostasis at different postpartum stages, the modulatory role of N‐acetylcysteine (NAC), and the effects on the offspring, including sex‐specific differences. Albino Wistar female and male rats were used; pregnant females received a single intraperitoneal injection of LPS (0.5 mg/kg) on gestational day 16, with a subset pretreated with NAC (300 mg/kg). Mothers were sacrificed at the end of gestation or on postpartum day 21 (PP21), and offspring were analyzed at PP21. Maternal glucose tolerance was assessed using OGTT, and HOMA‐IR and HOMA‐β indices were used to determine insulin resistance and β‐cell function. Maternal and offspring tissues were analyzed for key markers of signaling, autophagy, proliferation, apoptosis, and inflammation. Phosphorylated protein kinase B (p‐Akt), mammalian target of rapamycin (mTOR), Ki‐67 (a proliferation marker), phosphorylated AMP‐activated protein kinase (p‐AMPK), Beclin‐1, and microtubule‐associated protein 1 light chain 3 beta (LC3B) were measured in tissue homogenates; pancreatic insulin and pro‐insulin levels were determined; plasma cytokines, including interleukin‐6 (IL‐6), interleukin‐10 (IL‐10), tumor necrosis factor‐alpha (TNF‐α), and interferon‐gamma (IFN‐γ), as well as cleaved caspase‐3. All of them were quantified using enzyme‐linked immunosorbent assay (ELISA) kits. Total antioxidant capacity (TAC) and total oxidant status (TOS) were measured in plasma using colorimetric assays. At PP0, LPS decreased muscle glucose uptake, increased hepatic gluconeogenesis and glucose output, and enhanced pancreatic insulin production, autophagy, apoptosis, and proliferation while maintaining plasma glucose levels, indicating an adaptive response. NAC improved muscle glucose uptake, suppressed hepatic gluconeogenesis, and normalized pancreatic changes. At PP21, LPS exposure led to increased hepatic gluconeogenesis, impaired pancreatic function, and higher plasma glucose levels. NAC reduced hepatic gluconeogenesis but did not restore glucose balance and worsened pancreatic dysfunction. In offspring of LPS‐treated dams, IL‐6, TNF‐α, and IFN‐γ levels decreased, whereas IL‐10 increased only in females. Markers of pancreatic apoptosis, autophagy, and proliferation were reduced in both sexes. NAC exposure decreased IL‐10 and increased IL‐6, TNF‐α, and IFN‐γ in all offspring and selectively enhanced pancreatic markers in males. Maternal LPS exposure differentially affected glucose regulation through the muscle, liver, and pancreas across postpartum stages. NAC exerted beneficial effects mainly in the early postpartum period but was insufficient later. Furthermore, NAC induced sex‐specific effects in the offspring, with a more substantial impact observed in males.
- 14 January 2026
- Published by Wiley in Journal of Applied Toxicology
- Vol. 46 (4) , 1372-1388
Maternal Immune Activation Disrupts Autophagy and Glucose Homeostasis: Experimental Evidence for the Protective Effects of N‐Acetylcysteine on Maternal and Offspring Outcomes in a Rat Model
Maternal immune activation during pregnancy has been shown to disrupt maternal glucose regulation, predisposing the mother to postpartum diabetic conditions while also exerting long‐lasting metabolic effects on the offspring. This study aimed to investigate the impact of lipopolysaccharide (LPS)‐induced maternal immune activation on glucose homeostasis at different postpartum stages, the modulatory role of N‐acetylcysteine (NAC), and the effects on the offspring, including sex‐specific differences. Albino Wistar female and male rats were used; pregnant females received a single intraperitoneal injection of LPS (0.5 mg/kg) on gestational day 16, with a subset pretreated with NAC (300 mg/kg). Mothers were sacrificed at the end of gestation or on postpartum day 21 (PP21), and offspring were analyzed at PP21. Maternal glucose tolerance was assessed using OGTT, and HOMA‐IR and HOMA‐β indices were used to determine insulin resistance and β‐cell function. Maternal and offspring tissues were analyzed for key markers of signaling, autophagy, proliferation, apoptosis, and inflammation. Phosphorylated protein kinase B (p‐Akt), mammalian target of rapamycin (mTOR), Ki‐67 (a proliferation marker), phosphorylated AMP‐activated protein kinase (p‐AMPK), Beclin‐1, and microtubule‐associated protein 1 light chain 3 beta (LC3B) were measured in tissue homogenates; pancreatic insulin and pro‐insulin levels were determined; plasma cytokines, including interleukin‐6 (IL‐6), interleukin‐10 (IL‐10), tumor necrosis factor‐alpha (TNF‐α), and interferon‐gamma (IFN‐γ), as well as cleaved caspase‐3. All of them were quantified using enzyme‐linked immunosorbent assay (ELISA) kits. Total antioxidant capacity (TAC) and total oxidant status (TOS) were measured in plasma using colorimetric assays. At PP0, LPS decreased muscle glucose uptake, increased hepatic gluconeogenesis and glucose output, and enhanced pancreatic insulin production, autophagy, apoptosis, and proliferation while maintaining plasma glucose levels, indicating an adaptive response. NAC improved muscle glucose uptake, suppressed hepatic gluconeogenesis, and normalized pancreatic changes. At PP21, LPS exposure led to increased hepatic gluconeogenesis, impaired pancreatic function, and higher plasma glucose levels. NAC reduced hepatic gluconeogenesis but did not restore glucose balance and worsened pancreatic dysfunction. In offspring of LPS‐treated dams, IL‐6, TNF‐α, and IFN‐γ levels decreased, whereas IL‐10 increased only in females. Markers of pancreatic apoptosis, autophagy, and proliferation were reduced in both sexes. NAC exposure decreased IL‐10 and increased IL‐6, TNF‐α, and IFN‐γ in all offspring and selectively enhanced pancreatic markers in males. Maternal LPS exposure differentially affected glucose regulation through the muscle, liver, and pancreas across postpartum stages. NAC exerted beneficial effects mainly in the early postpartum period but was insufficient later. Furthermore, NAC induced sex‐specific effects in the offspring, with a more substantial impact observed in males.
- 31 December 2025
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 8 (4) , 475-480
Retrospective Analysis Of Changes in Pseudocholinesterase (Butyrylcholinesterase) Values Based On Gender And Year
Aim: Pseudocholinesterase (PChE) serum PChE levels increase over time in different populations, leading to faster metabolism of anesthetic agents, shortening the duration of paralysis and requiring additional doses. This makes the assessment of serum PChE levels an important issue for anesthesia safety. Methods: In this retrospective cross-sectional study, preoperative serum PChE levels of 8.951 patients were examined over a seven-year period. Differences by year, the years between which the differences occurred, gender-related changes, and year-gender interactions were analyzed. Results: The mean serum PChE level in all patients was 10.621 ± 0.24 U/L. Linear regression analysis revealed a mean annual increase of 233.66 U/L across years. Male PChE levels were significantly higher than female PChE levels. The Year × Gender interaction was also found to be significant. Consequently, the rate of increase was found to be faster in males than in females. Furthermore, serum PChE levels were higher in females among individuals over 65 years of age. The highest serum PChE levels were observed in individuals under 15 years of age. Conclusions: Conclusions: Differences between men and women may be due to biological differences related to sex, while the overall increase over time may be due to metabolic changes or environmental factors within the population. Therefore, our results suggest that individual sex and hormonal variations, as well as trends in serum PChE levels across populations, may be critical for anesthesia safety.
- 31 December 2025
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 8 (4) , 475-480
Retrospective Analysis Of Changes in Pseudocholinesterase (Butyrylcholinesterase) Values Based On Gender And Year
Aim: Pseudocholinesterase (PChE) serum PChE levels increase over time in different populations, leading to faster metabolism of anesthetic agents, shortening the duration of paralysis and requiring additional doses. This makes the assessment of serum PChE levels an important issue for anesthesia safety. Methods: In this retrospective cross-sectional study, preoperative serum PChE levels of 8.951 patients were examined over a seven-year period. Differences by year, the years between which the differences occurred, gender-related changes, and year-gender interactions were analyzed. Results: The mean serum PChE level in all patients was 10.621 ± 0.24 U/L. Linear regression analysis revealed a mean annual increase of 233.66 U/L across years. Male PChE levels were significantly higher than female PChE levels. The Year × Gender interaction was also found to be significant. Consequently, the rate of increase was found to be faster in males than in females. Furthermore, serum PChE levels were higher in females among individuals over 65 years of age. The highest serum PChE levels were observed in individuals under 15 years of age. Conclusions: Conclusions: Differences between men and women may be due to biological differences related to sex, while the overall increase over time may be due to metabolic changes or environmental factors within the population. Therefore, our results suggest that individual sex and hormonal variations, as well as trends in serum PChE levels across populations, may be critical for anesthesia safety.
- 31 December 2025
- Published by Uludag Universitesi Veteriner Fakultesi Dergisi in Journal of Research in Veterinary Medicine
- Vol. 44 (2) , 81-89
Effects of Perga on FGF21/Leptin/Insulin in Imparied Glucose Regulation
Objective: This study aimed to investigate the effects of Perga supplementation on glucose metabolism, body weight regulation, and amyloid-beta (Aβ) accumulation in a streptozotocin (STZ)-induced type 2 diabetes (T2D) rat model, focusing specifically on insulin, leptin, and fibroblast growth factor 21 (FGF21) signaling pathways. Methods: Male Wistar rats were divided into Sham (S), T2D, and T2D+Perga (T2DP) groups. T2D was induced by a single intraperitoneal (i.p.) STZ injection (60 mg/kg). Perga (200 mg/kg/day) was administered to the T2DP group by gavage 14 days after diabetes induction. Plasma and brain insulin and leptin levels, liver and plasma FGF21 concentrations, Homeostasis Model Assessment of Beta Cell Function (HOMA-β) index, fasting glucose levels, body weight changes, and brain amyloid-beta (Aβ) accumulation were evaluated. Results: STZ-induced T2D resulted in hypoinsulinemia, decreased HOMA-β scores, weight loss, reduced plasma leptin, increased brain leptin, decreased FGF21 levels, and significant Aβ accumulation in the hippocampus. Perga treatment significantly improved plasma and brain insulin levels, increased HOMA-β, reduced fasting glucose, and attenuated weight loss. Plasma leptin levels returned to normal, brain leptin levels decreased, and hippocampus Aβ burden was significantly reduced. In addition, perga supplementation almost normalized liver and plasma FGF21 levels. Conclusion: Perga supplementation effectively ameliorates metabolic dysfunction and neurodegenerative markers in the T2D model. Its regulatory effects on insulin, leptin, and FGF21 signaling highlight its potential as a natural therapeutic agent in managing T2D and associated AD-like pathology. Further research is needed to evaluate its clinical applicability.
- 31 December 2025
- Published by Uludag Universitesi Veteriner Fakultesi Dergisi in Journal of Research in Veterinary Medicine
- Vol. 44 (2) , 81-89
Effects of Perga on FGF21/Leptin/Insulin in Imparied Glucose Regulation
Objective: This study aimed to investigate the effects of Perga supplementation on glucose metabolism, body weight regulation, and amyloid-beta (Aβ) accumulation in a streptozotocin (STZ)-induced type 2 diabetes (T2D) rat model, focusing specifically on insulin, leptin, and fibroblast growth factor 21 (FGF21) signaling pathways. Methods: Male Wistar rats were divided into Sham (S), T2D, and T2D+Perga (T2DP) groups. T2D was induced by a single intraperitoneal (i.p.) STZ injection (60 mg/kg). Perga (200 mg/kg/day) was administered to the T2DP group by gavage 14 days after diabetes induction. Plasma and brain insulin and leptin levels, liver and plasma FGF21 concentrations, Homeostasis Model Assessment of Beta Cell Function (HOMA-β) index, fasting glucose levels, body weight changes, and brain amyloid-beta (Aβ) accumulation were evaluated. Results: STZ-induced T2D resulted in hypoinsulinemia, decreased HOMA-β scores, weight loss, reduced plasma leptin, increased brain leptin, decreased FGF21 levels, and significant Aβ accumulation in the hippocampus. Perga treatment significantly improved plasma and brain insulin levels, increased HOMA-β, reduced fasting glucose, and attenuated weight loss. Plasma leptin levels returned to normal, brain leptin levels decreased, and hippocampus Aβ burden was significantly reduced. In addition, perga supplementation almost normalized liver and plasma FGF21 levels. Conclusion: Perga supplementation effectively ameliorates metabolic dysfunction and neurodegenerative markers in the T2D model. Its regulatory effects on insulin, leptin, and FGF21 signaling highlight its potential as a natural therapeutic agent in managing T2D and associated AD-like pathology. Further research is needed to evaluate its clinical applicability.
- 31 August 2025
- Published by Journal of Advances in VetBio Science and Techniques in Journal of Advances in VetBio Science and Techniques
- Vol. 10 (2) , 108-114
Investigation of the changes in hepatic 5-hydroxytryptamine 2A receptor levels caused by lipopolysaccharide of Porphyromonas gingivalis and the effect of Thymoquinone on these changes.
Background: The present study aimed to assess the effect of Porphyromonas gingivalis-Lipopolysaccharide (P.gingivalis-LPS) on hepatic disorder mediated by 5-hydroxytryptamine receptor 2A (HT2AR) and whether there is any impact of Thymoquinone (TQ) administration. Methods: 10 µl P. gingivalis-LPS (1mg/ml) injected 6 times at 48-hour intervals into the palatal gingiva of rats. TQ was given by oral gavage (10 mg/kg per day) for two weeks. HT2AR and pro-caspase-3 levels were measured by the enzyme-linked immunosorbent assay (ELISA). Morphological changes in the liver were identified by hematoxylin and eosin staining. Results: In the P.gingivalis-LPS injected group, the hepatic HT2AR levels increased while pro-caspase-3 levels decreased, disturbing the liver morphological structure. TQ administration increased pro-caspase-3 levels and improved morphological structure despite increased HT2AR levels. Conclusion: Our results suggest that oral application of P. gingivalis-LPS decreased pro-caspase 3, an inactive form of caspase-3 by HT2AR, probably due to increased cleaved caspase-3 levels, and TQ administration increased pro-caspase-3 levels, leading to improved liver morphological structure. Therephore, our study indicated that oral pathogen P. gingivalis might impact the liver HT2AR-mediated, and TQ may have a beneficial effect.
- 31 August 2025
- Published by Journal of Advances in VetBio Science and Techniques in Journal of Advances in VetBio Science and Techniques
- Vol. 10 (2) , 108-114
Investigation of the changes in hepatic 5-hydroxytryptamine 2A receptor levels caused by lipopolysaccharide of Porphyromonas gingivalis and the effect of Thymoquinone on these changes.
Background: The present study aimed to assess the effect of Porphyromonas gingivalis-Lipopolysaccharide (P.gingivalis-LPS) on hepatic disorder mediated by 5-hydroxytryptamine receptor 2A (HT2AR) and whether there is any impact of Thymoquinone (TQ) administration. Methods: 10 µl P. gingivalis-LPS (1mg/ml) injected 6 times at 48-hour intervals into the palatal gingiva of rats. TQ was given by oral gavage (10 mg/kg per day) for two weeks. HT2AR and pro-caspase-3 levels were measured by the enzyme-linked immunosorbent assay (ELISA). Morphological changes in the liver were identified by hematoxylin and eosin staining. Results: In the P.gingivalis-LPS injected group, the hepatic HT2AR levels increased while pro-caspase-3 levels decreased, disturbing the liver morphological structure. TQ administration increased pro-caspase-3 levels and improved morphological structure despite increased HT2AR levels. Conclusion: Our results suggest that oral application of P. gingivalis-LPS decreased pro-caspase 3, an inactive form of caspase-3 by HT2AR, probably due to increased cleaved caspase-3 levels, and TQ administration increased pro-caspase-3 levels, leading to improved liver morphological structure. Therephore, our study indicated that oral pathogen P. gingivalis might impact the liver HT2AR-mediated, and TQ may have a beneficial effect.
- Open Access
- 7 August 2025
- Published by Wiley
The complete manuscript title: Exploring the Hepato-Cardiac Axis in Epirubicin Toxicity: The Interplay of Kynurenine Pathway and Antioxidant Intervention with N-Acetylcysteine
Introduction: Epirubicin (EPI) is a widely used chemotherapeutic agent whose clinical use is limited by severe side effects, primarily due to oxidative stress-induced cardiotoxicity exacerbated by impaired hepatic clearance. This study investigated EPI-induced alterations in hepatic kynurenine pathway metabolites and their potential role in cardiotoxicity, as well as the protective effects of N-acetylcysteine (NAC). Methods: Rats received intraperitoneal injections of NAC (50 or 300 mg/kg) followed by EPI (9.6 mg/kg). Hepatic levels of tryptophan, kynurenine, kynurenic acid, quinolinic acid, kynureninase, kynurenine 3-monooxygenase, and cleaved caspase-3 were measured by ELISA. The total antioxidant and oxidant status in liver tissue was assessed colorimetrically. Plasma biomarkers, including AST, ALT, CK-MB, and lipids, were analyzed. Results: EPI significantly elevated plasma CK-MB, AST/ALT ratio, LDL, cholesterol, and triglycerides; NAC attenuated these effects. Hepatic kynurenine pathway dysregulation correlated positively with cardiotoxicity markers. Discussion: EPI disrupts hepatic kynurenine metabolism, contributing to cardiotoxicity, while NAC confers partial protection, likely via antioxidant and metabolic modulation mechanisms.
- 7 August 2025
- Published by Wiley
Open AccessThe complete manuscript title: Exploring the Hepato-Cardiac Axis in Epirubicin Toxicity: The Interplay of Kynurenine Pathway and Antioxidant Intervention with N-Acetylcysteine
Introduction: Epirubicin (EPI) is a widely used chemotherapeutic agent whose clinical use is limited by severe side effects, primarily due to oxidative stress-induced cardiotoxicity exacerbated by impaired hepatic clearance. This study investigated EPI-induced alterations in hepatic kynurenine pathway metabolites and their potential role in cardiotoxicity, as well as the protective effects of N-acetylcysteine (NAC). Methods: Rats received intraperitoneal injections of NAC (50 or 300 mg/kg) followed by EPI (9.6 mg/kg). Hepatic levels of tryptophan, kynurenine, kynurenic acid, quinolinic acid, kynureninase, kynurenine 3-monooxygenase, and cleaved caspase-3 were measured by ELISA. The total antioxidant and oxidant status in liver tissue was assessed colorimetrically. Plasma biomarkers, including AST, ALT, CK-MB, and lipids, were analyzed. Results: EPI significantly elevated plasma CK-MB, AST/ALT ratio, LDL, cholesterol, and triglycerides; NAC attenuated these effects. Hepatic kynurenine pathway dysregulation correlated positively with cardiotoxicity markers. Discussion: EPI disrupts hepatic kynurenine metabolism, contributing to cardiotoxicity, while NAC confers partial protection, likely via antioxidant and metabolic modulation mechanisms.
- 28 January 2025
- Published by Cappadocia University in Kapadokya Saglik Bilimleri Dergisi
Tükürük Kinürenin Yolu Metabolitleri Periodontitiste Psikolojik Stresin Bir Biyobelirteci Olabilir mi
Amaç: Bu çalışmada, periodontitisli (PD) bireylerin tükürük örneklerinde kortizol seviyeleri ve kinürenin (KYN) metabolizması değişiklikleri ile periodontal parametreler arasındaki ilişki araştırıldı. Yöntem: 20 periodontitis hastasından ve 20 periodontal olarak sağlıklı kontrol bireyinden tükürük örnekleri toplandı. Örnekler kortizol, interferon-gama (IFN-γ), Triptofan (TRP), KYN, kinürenik asit (KYNA) ve kinolinik asit (QA) açısından Elisa kiti ile ölçülerek analiz edildi. İndolamin-pirol 2,3-dioksijenaz (IDO) aktivitesi KYN/TRP oranı kullanılarak hesaplandı. Klinik periodontal parametreler olan (plak indeksi (PI), sondalama cebi derinliği (PPD), dişeti çekilmesi (GR), klinik ataşman kaybı (CAL) ve sondalama sırasında kanama (BOP) kaydedildi. Bulgular: Klinik parametreler periodontitis grubunda anlamlı derecede daha yüksekti (p<0,001). Tükürük Kortizol, IFN-γ, TRP, KYN, KYNA, QA düzeyleri ve KYN/TRP oranı periodontitis grubunda kontrol grubuna göre anlamlı derecede daha yüksekti (p<0,001). PPD, BOP, PI ve CAL tükürük kortizol düzeyleriyle anlamlı derecede pozitif korelasyon gösterdi. Ayrıca tükürük kortizol düzeyleri tükürük KYN/TRP oranıyla anlamlı derecede pozitif korelasyon gösterdi. Sonuç: Bulgularımız stres belirteci kortizolün periodontal inflamasyon ve triptofan-kinürenin metabolizmasında rol oynadığını göstermektedir. Anahtar Sözcükler:Kinürenin, Kortizol,Periodontitis, Stres
- 28 January 2025
- Published by Cappadocia University in Kapadokya Saglik Bilimleri Dergisi
Tükürük Kinürenin Yolu Metabolitleri Periodontitiste Psikolojik Stresin Bir Biyobelirteci Olabilir mi
Amaç: Bu çalışmada, periodontitisli (PD) bireylerin tükürük örneklerinde kortizol seviyeleri ve kinürenin (KYN) metabolizması değişiklikleri ile periodontal parametreler arasındaki ilişki araştırıldı. Yöntem: 20 periodontitis hastasından ve 20 periodontal olarak sağlıklı kontrol bireyinden tükürük örnekleri toplandı. Örnekler kortizol, interferon-gama (IFN-γ), Triptofan (TRP), KYN, kinürenik asit (KYNA) ve kinolinik asit (QA) açısından Elisa kiti ile ölçülerek analiz edildi. İndolamin-pirol 2,3-dioksijenaz (IDO) aktivitesi KYN/TRP oranı kullanılarak hesaplandı. Klinik periodontal parametreler olan (plak indeksi (PI), sondalama cebi derinliği (PPD), dişeti çekilmesi (GR), klinik ataşman kaybı (CAL) ve sondalama sırasında kanama (BOP) kaydedildi. Bulgular: Klinik parametreler periodontitis grubunda anlamlı derecede daha yüksekti (p<0,001). Tükürük Kortizol, IFN-γ, TRP, KYN, KYNA, QA düzeyleri ve KYN/TRP oranı periodontitis grubunda kontrol grubuna göre anlamlı derecede daha yüksekti (p<0,001). PPD, BOP, PI ve CAL tükürük kortizol düzeyleriyle anlamlı derecede pozitif korelasyon gösterdi. Ayrıca tükürük kortizol düzeyleri tükürük KYN/TRP oranıyla anlamlı derecede pozitif korelasyon gösterdi. Sonuç: Bulgularımız stres belirteci kortizolün periodontal inflamasyon ve triptofan-kinürenin metabolizmasında rol oynadığını göstermektedir. Anahtar Sözcükler:Kinürenin, Kortizol,Periodontitis, Stres
- 21 October 2024
- Published by Afyon Kocatepe University in Kocatepe Tıp Dergisi
- Vol. 25 (4) , 466-475
ARI EKMEĞİNİN ALZHEİMER SIÇAN MODELİNDE KARACİĞER 5HT2B ARACILI GLUKOZ DÜZENLEMESİ ÜZERİNE ETKİSİ
AMAÇ: Bu çalışmada Alzheimer hastalığının (AH) sıçan mo-delinde arı ekmeğinin insülin, serotonin (5-hidroksitriptamin, 5-HT) ve leptin hormonlarında meydana getireceği değişimin glukoz regülasyonu ve kilo değişimi üzerindeki etkisinin ince-lenmesi amaçlanmıştır.GEREÇ VE YÖNTEM: Alzheimer hastalığı sıçan modeli, lateral ventriküllere intraserebroventriküler (i.c.v.) Streptozotosin (STZ) enjeksiyonu yoluyla oluşturuldu. Arı ekmeği uygulaması, STZ enjeksiyonundan sonra 3 hafta boyunca oral gavaj ile gerçek-leştirildi. Plazmada leptin, insülin, 5-HT düzeyleri ile karaciğer dokusunda leptin, insülin, 5-HT, 5HT reseptör 2B (5HT2B), glu-koz taşıyıcı 2 (GLUT2), glukoz 6-fosfataz (G6paz) düzeyleri Elisa kit ile ölçüldü. Açlık kan glukoz düzeyleri glukometre kullanıla-rak ölçüldü ve İnsülin Direnci İçin Homeostatik Model Değer-lendirmesi (HOMA-IR) düzeyleri formül kullanılarak hesaplandı. Her bir sıçanın ağırlık değişimi, başlangıç ağırlıklarının son ağır-lıklarından çıkarılmasıyla hesaplandı. BULGULAR: AH grubunda bulunan sıçanların açlık kan glukoz, plazma insülin ve HOMA-IR düzeyleri ile karaciğer 5-HT, plazma 5-HT ve leptin düzeylerinin azaldığı, karaciğer 5-HT2B ve GLUT-2 düzeyleri ile kilo kaybının arttığı görüldü. Arı ekmeği teda-visinin bu hayvanlarda karaciğer 5-HT2B, G6paz düzeyleri ve plazma leptin düzeylerini önemli ölçüde artırdığı, ayrıca plazma 5-HT, karaciğer 5-HT ve GLUT-2 düzeyleri ile kilo kaybını belirgin şekilde artırdığı görüldü. Ayrıca arı ekmeğinin plazma insülin düzeyini etkilemeden açlık kan glukoz düzeylerini azalttığı sap-tandı. SONUÇ: Bu sonuçlar, AH grubundaki sıçanların karaciğer doku-sunda glukoz metabolizmasının anti-diyabetik savunma siste-mi oluşturacak şekilde modüle edildiğini gösterdi. Arı ekmeği uygulamasının Alzheimer oluşturulmuş sıçanlarda leptin aracılı insülin duyarlılığını artırarak açlık kan glukoz düzeylerini azalt-tığı saptandı.
- 21 October 2024
- Published by Afyon Kocatepe University in Kocatepe Tıp Dergisi
- Vol. 25 (4) , 466-475
ARI EKMEĞİNİN ALZHEİMER SIÇAN MODELİNDE KARACİĞER 5HT2B ARACILI GLUKOZ DÜZENLEMESİ ÜZERİNE ETKİSİ
AMAÇ: Bu çalışmada Alzheimer hastalığının (AH) sıçan mo-delinde arı ekmeğinin insülin, serotonin (5-hidroksitriptamin, 5-HT) ve leptin hormonlarında meydana getireceği değişimin glukoz regülasyonu ve kilo değişimi üzerindeki etkisinin ince-lenmesi amaçlanmıştır.GEREÇ VE YÖNTEM: Alzheimer hastalığı sıçan modeli, lateral ventriküllere intraserebroventriküler (i.c.v.) Streptozotosin (STZ) enjeksiyonu yoluyla oluşturuldu. Arı ekmeği uygulaması, STZ enjeksiyonundan sonra 3 hafta boyunca oral gavaj ile gerçek-leştirildi. Plazmada leptin, insülin, 5-HT düzeyleri ile karaciğer dokusunda leptin, insülin, 5-HT, 5HT reseptör 2B (5HT2B), glu-koz taşıyıcı 2 (GLUT2), glukoz 6-fosfataz (G6paz) düzeyleri Elisa kit ile ölçüldü. Açlık kan glukoz düzeyleri glukometre kullanıla-rak ölçüldü ve İnsülin Direnci İçin Homeostatik Model Değer-lendirmesi (HOMA-IR) düzeyleri formül kullanılarak hesaplandı. Her bir sıçanın ağırlık değişimi, başlangıç ağırlıklarının son ağır-lıklarından çıkarılmasıyla hesaplandı. BULGULAR: AH grubunda bulunan sıçanların açlık kan glukoz, plazma insülin ve HOMA-IR düzeyleri ile karaciğer 5-HT, plazma 5-HT ve leptin düzeylerinin azaldığı, karaciğer 5-HT2B ve GLUT-2 düzeyleri ile kilo kaybının arttığı görüldü. Arı ekmeği teda-visinin bu hayvanlarda karaciğer 5-HT2B, G6paz düzeyleri ve plazma leptin düzeylerini önemli ölçüde artırdığı, ayrıca plazma 5-HT, karaciğer 5-HT ve GLUT-2 düzeyleri ile kilo kaybını belirgin şekilde artırdığı görüldü. Ayrıca arı ekmeğinin plazma insülin düzeyini etkilemeden açlık kan glukoz düzeylerini azalttığı sap-tandı. SONUÇ: Bu sonuçlar, AH grubundaki sıçanların karaciğer doku-sunda glukoz metabolizmasının anti-diyabetik savunma siste-mi oluşturacak şekilde modüle edildiğini gösterdi. Arı ekmeği uygulamasının Alzheimer oluşturulmuş sıçanlarda leptin aracılı insülin duyarlılığını artırarak açlık kan glukoz düzeylerini azalt-tığı saptandı.